Publications by authors named "E M GAL"

New -substituted AB-type phenothiazinyl porphyrins and ferrocenylvinyl phenothiazinyl porphyrin were synthesised by Suzuki-Miyaura and Mizoroki-Heck cross-coupling reactions, respectively. The free porphyrins were further used in the synthesis of new indium(iii) or zinc(ii) porphyrin complexes. All porphyrins exhibit red fluorescence emission in solution, a property that remains unimpaired following internalisation in ovarian A2780 cancer cells, as evidenced by fluorescence microscopy images.

View Article and Find Full Text PDF

Purpose: This concurrent embedded-design study evaluated the initial efficacy of the Social Participation and Navigation (SPAN-ASD) remote intervention for autistic adolescents and young adults (AYA) in achieving personal goals and enhancing self-efficacy. The study also explored participants' experiences through follow-up interviews.

Methods: Twelve autistic AYA (9 male; 12-20 years, M = 16.

View Article and Find Full Text PDF

Heavy alcohol intake is one of the most common causes of acute pancreatitis (AP). We have previously shown that ethanol (EtOH) decreases the expression and activity of the cystic fibrosis transmembrane conductance regulator (CFTR), which plays a key role in alcohol-induced AP development. The prescription drug, Orkambi (a combination of ivacaftor and lumacaftor) can correct impaired CFTR function and expression in cystic fibrosis (CF) patients.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of MUC17 in pancreatic cancer (PC) progression, particularly under the influence of bile acids (BAs) and human serum from patients with pancreatic ductal adenocarcinoma (PDAC) and obstructive jaundice (OJ).
  • Researchers found that higher levels of MUC17 are linked with poorer survival outcomes in PDAC patients, with significantly reduced survival time associated with elevated MUC17 expression.
  • In laboratory tests, BAs and human serum treatment increased MUC17 levels and cell proliferation in PDAC cells, while reducing MUC17 led to decreased carcinogenic processes, highlighting MUC17 as a potential new biomarker for prognosis in PC.
View Article and Find Full Text PDF

The literature supports the benefits of medical cannabis for core and comorbid symptoms in autistic individuals and anxiety-related symptoms in individuals without autism. However, no study has specifically investigated how cannabidiol (CBD)-rich cannabis affects anxiety subtypes in autistic children or its relationship with restricted and repetitive behaviors and interests (RRBI). Understanding the effects of CBD-rich cannabis treatment on anxiety subtypes and RRBI could offer more precise treatment approaches to managing anxiety symptoms and reducing RRBI frequency in autistic children.

View Article and Find Full Text PDF